Evidence map›Paper›PMID 30965142›Full record

ArticleActa biomaterialia2019

Mesoporous bioactive glass/ɛ-polycaprolactone scaffolds promote bone regeneration in osteoporotic sheep.

N Gómez-Cerezo, L Casarrubios, M Saiz-Pardo, L Ortega, D de Pablo, I Díaz-Güemes, B Fernández-Tomé, S Enciso, F M Sánchez-Margallo, M T Portolés and 2 more

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

N Gómez-CerezoDepartamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital, 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Spain.
L CasarrubiosDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
M Saiz-PardoServicio de Anatomía Patológica. Hospital Clínico San Carlos, Facultad de Medicina Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
L OrtegaServicio de Anatomía Patológica. Hospital Clínico San Carlos, Facultad de Medicina Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
D de PabloServicio de Anatomía Patológica. Hospital Clínico San Carlos, Facultad de Medicina Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
I Díaz-GüemesCentro de Cirugía de Mínima Invasión Jesús Usón, Cáceres, Spain.
B Fernández-ToméCentro de Cirugía de Mínima Invasión Jesús Usón, Cáceres, Spain.
S EncisoCentro de Cirugía de Mínima Invasión Jesús Usón, Cáceres, Spain.
F M Sánchez-MargalloCentro de Cirugía de Mínima Invasión Jesús Usón, Cáceres, Spain.
M T PortolésDepartamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain. Electronic address: portoles@quim.ucm.es.
D ArcosDepartamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital, 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Spain. Electronic address: arcosd@ucm.es.
M Vallet-RegíDepartamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital, 12 de Octubre i+12, Plaza Ramón y Cajal s/n, 28040 Madrid, Spain; CIBER de Bioingeniería Biomateriales y Nanomedicina (CIBER-BBN), Spain. Electronic address: vallet@ucm.es.
Universidad Complutense de Madrid · ESCentro de Cirugía de Mínima Invasión Jesús Usón · ES

Funding

European Research Council 694160
6 · The paper itself

Abstract

Macroporous scaffolds made of a SiO

Indexed as

OsteoporosisPolyestersZoledronic AcidAnimalsBone RegenerationDisease Models, AnimalDrug ImplantsFemaleGlassHumansMiceOsteoblastsOsteoclastsOsteogenesisPorosityRAW 264.7 CellsDrug ImplantspolycaprolactonePolyestersZoledronic AcidBone regenerationMesoporous bioactive glassOsteoporosisScaffoldsZoledronic acid

Identifiers

PMID30965142
PMCPMC6726488
OpenAlexW2932955246

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.